Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
2351
CALL
DELISTED
Exact Sciences
EXAS
| $11.2M | ﹤0.01% |
84,300
| – | – |
|
|
CAJ
2352
DELISTED
Canon, Inc.
CAJ
| $11.1M | ﹤0.01% |
574,167
+348,210
| +154% | +$6.28M |
|
2353
Protagonist Therapeutics
PTGX
$9.44B
| $11.1M | ﹤0.01% |
551,787
+329,707
| +148% | +$7.1M |
|
2354
Amphastar Pharmaceuticals
AMPH
$916M
| $11.1M | ﹤0.01% |
552,880
+13,691
| +3% | +$266K |
|
2355
Goosehead Insurance
GSHD
$2.32B
| $11.1M | ﹤0.01% |
89,047
-123,354
| -58% | -$14.1M |
|
2356
Compañía de Minas Buenaventura
BVN
$8.67B
| $11M | ﹤0.01% |
906,342
-42,705
| -4% | -$521K |
|
|
MIC
2357
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $11M | ﹤0.01% |
293,939
-8,815
| -3% | -$271K |
|
2358
CALL
Humana
HUM
$46.2B
| $11M | ﹤0.01% |
26,900
-4,400
| -14% | -$1.83M |
|
|
CVET
2359
DELISTED
Covetrus, Inc. Common Stock
CVET
| $11M | ﹤0.01% |
383,845
-625,698
| -62% | -$16.9M |
|
|
THS
2360
DELISTED
Treehouse Foods
THS
| $11M | ﹤0.01% |
259,495
+22,454
| +9% | +$913K |
|
2361
NiSource
NI
$20.4B
| $11M | ﹤0.01% |
479,780
-1,621,798
| -77% | -$37.9M |
|
2362
Alector
ALEC
$198M
| $11M | ﹤0.01% |
727,385
+216,660
| +42% | +$2.69M |
|
2363
PUT
BioMarin Pharmaceuticals
BMRN
$12.3B
| $11M | ﹤0.01% |
125,500
+48,000
| +62% | +$3.81M |
|
|
ILPT
2364
Industrial Logistics Properties Trust
ILPT
$586M
| $11M | ﹤0.01% |
470,743
-25,814
| -5% | -$564K |
|
2365
PUT
Polaris
PII
$4.07B
| $11M | ﹤0.01% |
115,000
-25,800
| -18% | -$2.47M |
|
2366
Vanguard Russell 1000 Growth ETF
VONG
$45B
| $10.9M | ﹤0.01% |
176,304
+75,196
| +74% | +$4.4M |
|
2367
Schrodinger
SDGR
$1.36B
| $10.9M | ﹤0.01% |
137,540
-197,889
| -59% | -$12.4M |
|
2368
CALL
Merck
MRK
$318B
| $10.9M | ﹤0.01% |
139,279
-451,793
| -76% | -$34.6M |
|
2369
OneSpaWorld
OSW
$2.66B
| $10.8M | ﹤0.01% |
1,068,827
+4,757
| +0.4% | +$37.6K |
|
2370
iShares International Equity Factor ETF
INTF
$3.72B
| $10.8M | ﹤0.01% |
397,370
-47,630
| -11% | -$1.22M |
|
|
DCH
2371
Dauch Corp
DCH
$1.51B
| $10.8M | ﹤0.01% |
1,294,515
+204,633
| +19% | +$1.54M |
|
|
BHVN
2372
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.8M | ﹤0.01% |
+125,700
| New | +$10.7M |
|
|
CPRX
2373
DELISTED
Catalyst Pharmaceutical
CPRX
| $10.8M | ﹤0.01% |
3,222,590
+691,102
| +27% | +$2.32M |
|
2374
Armstrong World Industries
AWI
$7.84B
| $10.7M | ﹤0.01% |
144,441
+2,757
| +2% | +$199K |
|
2375
Vanguard World Funds Extended Duration ETF
EDV
$3.27B
| $10.7M | ﹤0.01% |
70,382
+68,901
| +4,652% | +$11M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.